Liewei Wang
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
-
- Gene expression and cancer classification 17
- Bioinformatics and Genomic Networks 16
- DNA Repair Mechanisms 13
-
- Cancer Genomics and Diagnostics 31
- Co-authors
- Richard M. Weinshilboum (108 shared papers)Krishna R. Kalari (68 shared papers)Zhenkun Lou (19 shared papers)Gregory D. Jenkins (37 shared papers)Brooke L. Fridley (33 shared papers)Nifang Niu (19 shared papers)Howard L. McLeod (1 shared paper)Liang Li (13 shared papers)
- Journals
- Cancer Research (15 papers)Pharmacogenetics and Genomics (13 papers)Journal of Clinical Oncology (10 papers)PLoS ONE (9 papers)Clinical Pharmacology & Therapeutics (7 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Liewei Wang
226 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Pharmacology 958
- Cancer Research 1.6k
- Biological Psychiatry 208
- Oncology 2.0k
- Molecular Biology 4.7k
Countries citing papers authored by Liewei Wang
This map shows the geographic impact of Liewei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liewei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liewei Wang more than expected).
Fields of papers citing papers by Liewei Wang
This network shows the impact of papers produced by Liewei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liewei Wang. The network helps show where Liewei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liewei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt Hit paper breakdown → | 2009 | 568 |
| 2 | Genomics and Drug Response Hit paper breakdown → | 2011 | 390 |
| 3 | 2011 | 334 | |
| 4 | 1999 | 290 | |
| 5 | 2013 | 275 | |
| 6 | 2004 | 192 | |
| 7 | 2005 | 155 | |
| 8 | 2010 | 154 | |
| 9 | 2017 | 146 | |
| 10 | 2016 | 144 | |
| 11 | 2019 | 142 | |
| 12 | 2017 | 138 | |
| 13 | 2008 | 137 | |
| 14 | 2012 | 137 | |
| 15 | 2016 | 134 | |
| 16 | 2019 | 127 | |
| 17 | 2006 | 121 | |
| 18 | 2015 | 118 | |
| 19 | 2010 | 116 | |
| 20 | 2016 | 114 |
About Liewei Wang
Liewei Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 233 papers that have together received 8.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (31 papers), Pharmacogenetics and Drug Metabolism (24 papers), Estrogen and related hormone effects (22 papers), Prostate Cancer Treatment and Research (20 papers), Gene expression and cancer classification (17 papers), Bioinformatics and Genomic Networks (16 papers), DNA Repair Mechanisms (13 papers) and Treatment of Major Depression (13 papers). The work is most often cited by research in Pharmacology (958 citations), Cancer Research (1.6k citations), Biological Psychiatry (208 citations), Oncology (2.0k citations) and Molecular Biology (4.7k citations). Liewei Wang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Richard M. Weinshilboum, Krishna R. Kalari, Zhenkun Lou, Gregory D. Jenkins, Brooke L. Fridley, Nifang Niu, Howard L. McLeod, Liang Li, Jia Yu and André Terzic. Their work appears in journals such as Cancer Research, Pharmacogenetics and Genomics, Journal of Clinical Oncology, PLoS ONE and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.